This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer.
No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and established prostate cancer management guidelines. Participation in the study will not influence treatment decisions.
Patient is an adult biological male.
Patient has morphologically confirmed and untreated prostate cancer.
Patient who will be treated with open, laparoscopic or robot-assisted laparoscopic radical prostatectomy.
Patient is informed about this observational study and has signed the informed consent form.
Patient has radiologically of morphologically confirmed prostate cancer metastases before the operation.
Patient received neoadjuvant prostate cancer treatment.
Patient is set to receive adjuvant treatment.
Patient has any contraindications for the operation.